Literature DB >> 17279628

Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

Morgane Rouault1, Catherine Le Calvez, Eric Boilard, Fanny Surrel, Alan Singer, Farideh Ghomashchi, Sofiane Bezzine, Sabine Scarzello, James Bollinger, Michael H Gelb, Gérard Lambeau.   

Abstract

To date, 12 secreted phospholipases A2 (sPLA2s) have been identified in the mouse species and divided into three structural collections (I/II/V/X, III, and XII). On the basis of their different molecular properties and tissue distributions, each sPLA2 is likely to exert distinct functions by acting as an enzyme or ligand for specific soluble proteins or receptors, among which the M-type receptor is the best-characterized target. Here, we present the properties of binding of the full set of mouse sPLA2s to the mouse M-type receptor. All enzymes have been produced in Escherichia coli or insect cells, and their properties of binding to the cloned and native M-type receptor have been determined. sPLA2s IB, IIA, IIE, IIF, and X are high-affinity ligands (K0.5 = 0.3-3 nM); sPLA2s IIC and V are low-affinity ligands (K0.5 = 30-75 nM), and sPLA2s IID, III, XIIA, and XIIB bind only very weakly or do not bind to the M-type receptor (K0.5 > 100 nM). Three exogenous parvoviral group XIII PLA2s and two fungal group XIV sPLA2s do not bind to the receptor. Together, these results indicate that the mouse M-type receptor is selective for only a subset of mouse sPLA2s from the group I/II/V/X structural collection. Binding of mouse sPLA2s to a recombinant soluble mouse M-type receptor leads in all cases to inhibition of enzymatic activity, and the extent of deglycosylation of the receptor decreases yet does not abolish sPLA2 binding. The physiological meaning of binding of sPLA2 to the M-type receptor is discussed on the basis of our current knowledge of sPLA2 functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279628     DOI: 10.1021/bi062119b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  Enhanced protein expression in mammalian cells using engineered SUMO fusions: secreted phospholipase A2.

Authors:  Raymond J Peroutka; Nabil Elshourbagy; Tara Piech; Tauseef R Butt
Journal:  Protein Sci       Date:  2008-06-06       Impact factor: 6.725

2.  The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice.

Authors:  D Y Hui; M J Cope; E D Labonté; H-T Chang; J Shao; E Goka; A Abousalham; D Charmot; J Buysse
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells.

Authors:  Caroline E von Allmen; Nicole Schmitz; Monika Bauer; Heather J Hinton; Michael O Kurrer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Tim Sparwasser; Roger R Beerli; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

4.  Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.

Authors:  Henrik J Jürgensen; Kristina Johansson; Daniel H Madsen; Astrid Porse; Maria C Melander; Kristine R Sørensen; Christoffer Nielsen; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

5.  Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the mammary gland.

Authors:  Eyal Seroussi; Shelly Klompus; Maayan Silanikove; Oleg Krifucks; Fira Shapiro; Arieh Gertler; Gabriel Leitner
Journal:  Immunogenetics       Date:  2013-10-03       Impact factor: 2.846

6.  Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators.

Authors:  Fanny Surrel; Ikram Jemel; Eric Boilard; James G Bollinger; Christine Payré; Carine M Mounier; Kati A Talvinen; Veli J O Laine; Timo J Nevalainen; Michael H Gelb; Gérard Lambeau
Journal:  Mol Pharmacol       Date:  2009-07-14       Impact factor: 4.436

7.  Distribution of secretory phospholipase A2 XIIA in the brain and its role in lipid metabolism and cognition.

Authors:  Sze-Min Ee; Yew-Long Lo; Guanghou Shui; Markus R Wenk; Eun-Joo Shin; Hyoung-Chun Kim; Wei-Yi Ong
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

8.  Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugs.

Authors:  Renato Rosseto; Joseph Hajdu
Journal:  Chem Phys Lipids       Date:  2010-01       Impact factor: 3.329

9.  Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease.

Authors:  Sarah Gora; Claire Perret; Ikram Jemel; Viviane Nicaud; Gérard Lambeau; François Cambien; Ewa Ninio; Stefan Blankenberg; Laurence Tiret; Sonia-Athina Karabina
Journal:  J Mol Med (Berl)       Date:  2009-06-03       Impact factor: 4.599

10.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.